Adverse Reactions to the Orphan Drug Cerliponase Alfa in the Treatment of Neurolipofuscinosis Type 2 (CLN2) by Ilaria Ammendolia, Maria Sframeli, Emanuela Esposito, Luigi Cardia, Alberto Noto, Mariaconcetta Currò, Gioacchino Calapai, Maria De Pasquale, Carmen Mannucci, Fabrizio Calapai

Subjects: Get full text

Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database by Atul Khurana, Syed Arman Rabbani, Mohamed El-Tanani, Mandeep Kumar Arora, Shrestha Sharma, Harikesh Dubey, Alaa A. Aljabali, Murtaza M. Tambuwala

Subjects: Get full text

Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance by Ioana Rada Popa Ilie, Carmen Maximiliana Dobrea, Anca Butuca, Calin Homorodean, Claudiu Morgovan, Andreea Loredana Vonica-Tincu, Felicia Gabriela Gligor, Steliana Ghibu, Adina Frum

Subjects: Get full text